First Horizon Advisors’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-534
| Closed | -$3.12K | – | 2537 |
|
|
2025
Q1 | $3.12K | Sell |
534
-698
| -57% | -$3.68K | ﹤0.01% | 1898 |
|
|
2024
Q4 | $4.58K | Sell |
1,232
-46
| -4% | -$212 | ﹤0.01% | 1819 |
|
|
2024
Q3 | $7.14K | Buy |
1,278
+688
| +117% | +$4.81K | ﹤0.01% | 1715 |
|
|
2024
Q2 | $4.97K | Buy |
590
+107
| +22% | +$1.14K | ﹤0.01% | 1762 |
|
|
2024
Q1 | $6.97K | Hold |
483
| – | – | ﹤0.01% | 1722 |
|
|
2023
Q4 | $10.4K | Buy |
483
+171
| +55% | +$3.05K | ﹤0.01% | 1584 |
|
|
2023
Q3 | $6K | Buy |
312
+75
| +32% | +$1.6K | ﹤0.01% | 1701 |
|
|
2023
Q2 | $6.03K | Buy |
237
+1
| +0.4% | +$29 | ﹤0.01% | 1737 |
|
|
2023
Q1 | $8.53K | Sell |
236
-22
| -9% | -$773 | ﹤0.01% | 1615 |
|
|
2022
Q4 | $10.2K | Buy |
258
+53
| +26% | +$2.2K | ﹤0.01% | 1547 |
|
|
2022
Q3 | $10K | Buy |
205
+6
| +3% | +$278 | ﹤0.01% | 1528 |
|
|
2022
Q2 | $9K | Buy |
199
+187
| +1,558% | +$10.3K | ﹤0.01% | 1645 |
|
|
2022
Q1 | $1K | Buy |
12
+8
| +200% | +$577 | ﹤0.01% | 1673 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 2467 |
|
|
2021
Q3 | $0 | Buy |
+4
| New | +$524 | ﹤0.01% | 2448 |
|
Other funds holding NVRO
First Horizon Advisors's NVRO Position: Q2 2025 in Review
First Horizon Advisors sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 534 shares — an estimated $3.12K sold.
First Horizon Advisors first reported a position in NVRO in Q3 2021 and held it in 15 quarters. The position peaked at $10.4K in Q4 2023. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- First Horizon Advisors reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- First Horizon Advisors sold 534 NEVRO CORP. shares in Q2 2025, an estimated $3.12K.
- First Horizon Advisors first reported a position in NEVRO CORP. in Q3 2021 and held it in 15 quarters.
- First Horizon Advisors's NEVRO CORP. position peaked at $10.4K in Q4 2023.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.